Maxwell Simkoff - Mar 3, 2023 Form 4 Insider Report for Doma Holdings, Inc. (DOMA)

Signature
/s/ Christian Ameri, as Attorney-in-Fact for Maxwell Simkoff
Stock symbol
DOMA
Transactions as of
Mar 3, 2023
Transactions value $
-$32,645
Form type
4
Date filed
3/6/2023, 03:49 PM
Previous filing
Feb 28, 2023
Next filing
Apr 4, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DOMA Common stock Sale -$32.6K -56.8K -1.09% $0.58 5.16M Mar 3, 2023 Direct F1, F2
holding DOMA Common stock 45M Mar 3, 2023 By The Saslaw-Simkoff Revocable Trust F3
holding DOMA Common stock 706K Mar 3, 2023 By Maxwell Simkoff 2023 GRAT F4
holding DOMA Common stock 706K Mar 3, 2023 By Jennifer Saslaw 2023 GRAT F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 As previously reported, on June 29, 2022 (the "Date of Grant"), the reporting person was granted 2,435,325 restricted stock units ("RSUs") under the Doma Holdings, Inc.'s (the "Company") Omnibus Incentive Plan (the "Plan"), representing the right to receive shares of Company common stock in the future. The grant vests as follows: 1/16th of the total RSUs will vest on each successive Scheduled Vesting Date (as defined below) following the Date of Grant, with a "Scheduled Vesting Date" being September 1, December 1, March 1 and June 1 of the applicable year, provided the reporting person is continuously employed through such date as applicable, with the first 1/16th of the RSUs vesting on September 1, 2022 and the final 1/16th of the RSUs vesting on September 1, 2026. On March 1, 2023, 152,208 shares of such RSUs vested. In connection with this vesting, 56,774 shares were sold on March 3, 2023 to satisfy the reporting person's tax withholding obligations.
F2 The price reported above in Column 4 represents a weighted average sales price. This transaction was executed in multiple trades at prices ranging from $0.54 to $0.59, inclusive. The reporting person hereby undertakes to provide, upon request, to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, full information regarding the number of shares and prices at which the transaction was effected.
F3 These shares are owned directly by The Saslaw-Simkoff Revocable Trust and indirectly by Maxwell Simkoff as trustee of the trust. The reporting person disclaims beneficial ownership except to the extent of his pecuniary interest therein.
F4 These shares are owned directly by the Maxwell Simkoff 2023 GRAT. The reporting person disclaims beneficial ownership except to the extent of his pecuniary interest therein.
F5 These shares are held for the benefit of the reporting person's wife. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.